Status:
COMPLETED
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
Lead Sponsor:
Vistakon Pharmaceuticals
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
8+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis
Eligibility Criteria
Inclusion
- history of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees within the past 24 months; successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more
Exclusion
- active ocular infection; clinically significant blepharitis; follicular conjunctivitis; pterygium; narrow angle glaucoma; dry eye syndrome; ocular surgery within past 6 months; pregnancy or lactation
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00432757
Start Date
January 1 2007
End Date
March 1 2007
Last Update
April 9 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles, California, United States
2
Charlotte, North Carolina, United States
3
Memphis, Tennessee, United States